Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Andrology: Testosterone and cardiovascular risk--deciphering the statistics.

Literature DB >> 24535586

Andrology: Testosterone and cardiovascular risk--deciphering the statistics.

Abraham Morgentaler¹, Ravi Kacker¹.

Abstract

Entities: Chemical

Mesh：

Substances：
Testosterone

Year: 2014 PMID： 24535586 DOI： 10.1038/nrurol.2014.24

Source DB: PubMed Journal: Nat Rev Urol ISSN： 1759-4812 Impact factor: 14.432

× No keyword cloud information.

10 in total

Review 1. Risks of testosterone-replacement therapy and recommendations for monitoring.

Authors: Ernani Luis Rhoden; Abraham Morgentaler
Journal: N Engl J Med Date: 2004-01-29 Impact factor: 91.245

2. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.

Authors: Vakkat Muraleedharan; Hazel Marsh; Dheeraj Kapoor; Kevin S Channer; T Hugh Jones
Journal: Eur J Endocrinol Date: 2013-10-21 Impact factor: 6.664

Review 3. A new era of testosterone and prostate cancer: from physiology to clinical implications.

Authors: Mohit Khera; David Crawford; Alvaro Morales; Andrea Salonia; Abraham Morgentaler
Journal: Eur Urol Date: 2013-08-16 Impact factor: 20.096

Review 4. Testosterone deficiency.

Authors: Abdulmaged M Traish; Martin M Miner; Abraham Morgentaler; Michael Zitzmann
Journal: Am J Med Date: 2011-07 Impact factor: 4.965

Review 5. Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data.

Authors: Culley C Carson; Giuseppe Rosano
Journal: J Sex Med Date: 2011-06-15 Impact factor: 3.802

6. Adverse events associated with testosterone administration.

Authors: Shehzad Basaria; Andrea D Coviello; Thomas G Travison; Thomas W Storer; Wildon R Farwell; Alan M Jette; Richard Eder; Sharon Tennstedt; Jagadish Ulloor; Anqi Zhang; Karen Choong; Kishore M Lakshman; Norman A Mazer; Renee Miciek; Joanne Krasnoff; Ayan Elmi; Philip E Knapp; Brad Brooks; Erica Appleman; Sheetal Aggarwal; Geeta Bhasin; Leif Hede-Brierley; Ashmeet Bhatia; Lauren Collins; Nathan LeBrasseur; Louis D Fiore; Shalender Bhasin
Journal: N Engl J Med Date: 2010-06-30 Impact factor: 91.245

7. Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men?

Authors: Matthew D L O'Connell; Stephen A Roberts; Upendram Srinivas-Shankar; Abdelouahid Tajar; Martin J Connolly; Judith E Adams; Jackie A Oldham; Frederick C W Wu
Journal: J Clin Endocrinol Metab Date: 2010-11-17 Impact factor: 5.958

8. Testosterone treatment and mortality in men with low testosterone levels.

Authors: Molly M Shores; Nicholas L Smith; Christopher W Forsberg; Bradley D Anawalt; Alvin M Matsumoto
Journal: J Clin Endocrinol Metab Date: 2012-04-11 Impact factor: 5.958

9. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.

Authors: Rebecca Vigen; Colin I O'Donnell; Anna E Barón; Gary K Grunwald; Thomas M Maddox; Steven M Bradley; Al Barqawi; Glenn Woning; Margaret E Wierman; Mary E Plomondon; John S Rumsfeld; P Michael Ho
Journal: JAMA Date: 2013-11-06 Impact factor: 56.272

Review 10. Testosterone and the cardiovascular system: a comprehensive review of the clinical literature.

Authors: Peyman Mesbah Oskui; William J French; Michael J Herring; Guy S Mayeda; Steven Burstein; Robert A Kloner
Journal: J Am Heart Assoc Date: 2013-11-15 Impact factor: 5.501

10 in total

7 in total

Andrology: Testosterone and cardiovascular risk--deciphering the statistics.

Review 1. Risks of testosterone-replacement therapy and recommendations for monitoring.

2. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.

Review 3. A new era of testosterone and prostate cancer: from physiology to clinical implications.

Review 4. Testosterone deficiency.

Review 5. Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data.

6. Adverse events associated with testosterone administration.

7. Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men?

8. Testosterone treatment and mortality in men with low testosterone levels.

9. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.

Review 10. Testosterone and the cardiovascular system: a comprehensive review of the clinical literature.

1. Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy.

2. The implications of low testosterone on mortality in men.

Review 3. Role of Testosterone in the Treatment of Cardiovascular Disease.

Review 4. The practical management of testosterone deficiency in men.

Review 5. Vascular Pathways of Testosterone: Clinical Implications.

6. The emancipation of testosterone from niche hormone to multi-system player.

Review 7. Hypogonadism and erectile dysfunction as harbingers of systemic disease.